Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma

Access Activity

Overview / Abstract:


Soft tissue sarcomas are a heterogeneous group of malignancies that arise primarily from the mesodermal tissues of the extremities, trunk and retroperitoneum, and head and neck. An estimated 13,130 new cases are diagnosed in the United States annually and 5,350 people die of the disease. Surgical resection is the mainstay of treatment for localized soft tissue sarcoma, with radiation and chemotherapy commonly used as adjuncts. However, nearly 50% of patients will experience locoregional recurrence, distant metastases, or both. The outlook for those with unresectable and metastatic disease is poor, with median overall survival in the order of 1 year.


Medical oncologists, surgical oncologists, radiation oncologists, pathologists, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with soft tissue sarcoma.


Upon completion of this activity, participants should be able to:

1.) Distinguish patient and tumor characteristics that can inform personalized therapeutic approaches in soft tissue sarcoma
2.) Evaluate the clinical relevance of emerging data in the management of advanced soft tissue sarcoma
3.) Assess strategies to manage adverse events and optimize treatment outcomes of patients with advanced soft tissue sarcoma


Oct 29, 2021


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

0.75 CME/NCPD, 0.4 hours of pharmacotherapy credit



Presenters / Authors / Faculty


Vicki L. Keedy, MD, MSCI (Chairperson)
Associate Professor of Medicine Clinical Director, Sarcoma
Vanderbilt-Ingram Cancer Center

Brian P. Rubin, MD, PhD
Institute Chairman
Robert J. Tomsich Pathology and Laboratory Medicine Institute
Cleveland Clinic

Kathleen Polson, NP
Nurse Practitioner
Dana-Farber Cancer Institute

Activity Specialities / Related Topics

Oncology / Cancer / Radiation Therapy, Pathology

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from Deciphera Pharmaceuticals, Inc., Epizyme, and Eisai.

Keywords / Search Terms

i3 Health oncology, CME, CNE, NCPD, CE, free CME, free NCPD, ILNA points, free ILNA points, MOC Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map